National trial safely scales back prescribing of a powerful antipsychotic for the elderly

Warning letters from Medicare can safely cut prescribing of a powerful but risky antipsychotic, according to a new study at Columbia University Mailman School of Public Health. Researchers used Medicare data to study the effects of the letters on hundreds of thousands of older adults with dementia.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup